Skip to content

Choline fenofibrate

Trilipix (choline fenofibrate) is a small molecule pharmaceutical. Choline fenofibrate was first approved as Trilipix on 2008-12-15. Trilipix's patent is valid until 2025-01-07 (FDA).
Trade Name Trilipix
Common Name Choline fenofibrate
Indication
Drug Class Antihyperlipidemics (clofibrate type)
Choline fenofibrate
Get full access now